Exchange Traded Concepts’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Exchange Traded Concepts’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-48,510	Closed	-$196K	–	1473
2023 Q4	$196K	Buy	48,510 +12,300	+34%	+$37.5K	0.01%	789
2023 Q3	$97.4K	Buy	36,210 +21,419	+145%	+$84K	﹤0.01%	905
2023 Q2	$138K	Buy	+14,791	New	+$146K	﹤0.01%	867

Exchange Traded Concepts's THRX Position: Q1 2024 in Review

Exchange Traded Concepts sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 48,510 shares — an estimated $196K sold.

Exchange Traded Concepts first reported a position in THRX in Q2 2023 and held it in 3 quarters. The position peaked at $196K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Exchange Traded Concepts reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Exchange Traded Concepts sold 48,510 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $196K.
Exchange Traded Concepts first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
Exchange Traded Concepts's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $196K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Exchange Traded Concepts's 13F filing for Q1 2024, filed 15 Apr 2024.